One of the largest artificial intelligence chip companies out of Silicon Valley is coming for Wall Street next.
What’s happening:
- Artificial intelligence chip company Cerebras has filed an S-1 with the United States Securities and Exchange Commission to formally register for an IPO to list onto the Nasdaq Global Market
Why it matters:
- Cerebras is one of the largest venture backed companies manufacturing next generation chips for artificial intelligence computing and has made significant technological breakthroughs in developing chips with new capabilities
- Cerebras also recently launched the fastest inference technology in the world for artificial intelligence workloads which is capable of performing both faster and cheaper on open source models compared to GPUs
By the numbers:
- Cerebras has raised $720M USD in venture capital funding since inception
- The inference technology developed by Cerebras runs at 20x the speed of GPUs and at 20% of the total cost
- Abu Dhabi based technology group G42 previously committed to purchasing $1.5B USD of chips and cloud computing from Cerebras
Going deeper:
- Cerebras has launched multiple notable partnerships focused on leveraging their chips and technology, including the Mayo Clinic, AstraZeneca (NASDAQ: AZN) and the United States Department of Energy’s National Energy Technology Laboratory
The intrigue:
- OpenAI co-founder Sam Altman is also an early stage investor in Cerebras
